ClinicalTrials.gg
Enrolling by invitationNCT07128953ZQSUpdated Aug 19, 2025

Study on the Mechanism of Zuoqing San Promoting Postoperative Wound Healing of Anal Fistula by Inhibiting ROS-dependent NETosis

An Early Phase 1 interventional study of Solution of Zuoqing San for fumigation and washing of the postoperative wound of anal fistula and Equal-volume placebo inhalation rinse in Anal Fistula, sponsored by The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine. Enrolling by invitation at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-19.

Sponsored by The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine · Early Phase 1, Interventional, and Treatment

Phase
Early Phase 1
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study adopted a randomized, double-blind, placebo-controlled clinical trial design to evaluate the efficacy and safety of Zuoqing San fumigation and washing on the wound healing after anal fistula surgery.

Read the detailed description

A total of 60 patients who underwent anal fistula surgery at the Second Affiliated Hospital of Anhui University of Chinese Medicine from September 2024 to March 2025 were included. They were randomly divided into the experimental group (treated with Left Qing San fumigation and washing) and the control group (treated with placebo fumigation and washing) at a ratio of 1:1.

02

Conditions studied

  • Anal Fistula

Browse trials for

Keywords

  • Anal fistula
03

In context

Rectal Fistula

169 studies on the registry are indexed under Rectal Fistula; 45 are open to participants now.

This study's planned enrollment of 60 is close to the median of 66 across 115 interventional studies indexed under Rectal Fistula.

Browse Rectal Fistula studies →

Lead sponsor

The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine is the lead sponsor of 7 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Recurrent swelling and pain, along with pus discharge around the anus;
  • Preoperative MRI or ultrasound confirmed the presence of the fistula;
  • Underwent incision of the anal fistula, with the postoperative wound diameter ranging from 2 to 4 cm.

Exclusion criteria

Exclusion Criteria:

  1. Inflammatory bowel disease (such as Crohn's disease) related anal fistula;
  2. Complicated with severe dysfunction of heart, liver and kidney (/AST > 2 times upper limit, Cr > 1.5 mg/dL);
  3. Pregnant or lactating women;
  4. Those who are known to be allergic to the components of Zuoqing San;
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ALT and AST (liver enzymes)

Two enzymes measured in a routine blood test of the liver. Higher levels can mean the liver is under strain or damaged. SGPT and SGOT are older names for ALT and AST.

Criteria usually give a limit as a multiple of the upper limit of normal (ULN), often higher when cancer has spread to the liver.

05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Study Group

    ZQS

    Drug: Solution of Zuoqing San for fumigation and washing of the postoperative wound of anal fistula

  • Placebo comparator
    control Group

    Control

    Other: Equal-volume placebo inhalation rinse

Interventions

  • DrugSolution of Zuoqing San for fumigation and washing of the postoperative wound of anal fistula

    Left Qing San Decoction (25g of Cai Yin + 30g of Eucommia + 25g of Sophora flavescens + 25g of Anemarrhena asphodeloides + 15g of Lithospermum erythrorhizon, prepared in the Pharmacy Department of Anhui University of Traditional Chinese Medicine), add 1000mL of water, boil, then steam and wash the wound surface. The temperature is 40 ± 2℃. Do it once a day, for 15 minutes each time, for 7 consecutive days.

  • OtherEqual-volume placebo inhalation rinse

    Equal-volume placebo inhalation rinse

06

What researchers measure

Primary outcomes

  1. Wound healing time

    The number of days from the day after the operation until the wound surface is completely covered by epithelium (as observed by the naked eye, there is no exudation, and upon palpation, the scar is smooth).

    Time frame: From postoperative day 1 until wound healing is achieved (assessed daily during hospitalization and weekly after discharge, up to 8 weeks)

07

Study locations

1 site
  • Anhui university of Chinese Medicine
    Hefei, Anhui 230000, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07128953
Lead sponsor
The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Responsible party
Heng Deng (The First Affiliated Hospital of Anhui University of Chinese Medicine, The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine) — Principal investigator
First posted
Aug 19, 2025
Start date
Aug 1, 2025
Primary completion
Aug 2, 2025
Completion
Feb 1, 2026 (estimated)
Last update
Aug 19, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion